Owen N. Witte's most recent trade in Allogene Therapeutics Inc was a trade of 95,400 Restricted Stock Unit done . Disclosure was reported to the exchange on June 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Allogene Therapeutics Inc | Owen N. Witte | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 95,400 | 95,400 | - | - | Restricted Stock Unit | |
| Allogene Therapeutics Inc | Owen N. Witte | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 191,082 | 191,082 | - | - | Stock Option (Right to buy) | |
| Allogene Therapeutics Inc | Owen N. Witte | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 74,561 | 292,832 (0%) | 0% | 0 | Common Stock | |
| Allogene Therapeutics Inc | Owen N. Witte | Director | Sale of securities on an exchange or to another person at price $ 16.50 per share. | 11 Aug 2022 | 10,000 | 223,271 (0%) | 0% | 16.5 | 165,000 | Common Stock |
| Allogene Therapeutics Inc | Owen N. Witte | Director | Sale of securities on an exchange or to another person at price $ 16.50 per share. | 11 Aug 2022 | 10,000 | 223,271 (0%) | 0% | 16.5 | 165,000 | Common Stock |
| Allogene Therapeutics Inc | Owen N. Witte | Director | Sale of securities on an exchange or to another person at price $ 17.25 per share. | 11 Aug 2022 | 5,000 | 218,271 (0%) | 0% | 17.3 | 86,250 | Common Stock |
| Allogene Therapeutics Inc | Owen N. Witte | Director | Sale of securities on an exchange or to another person at price $ 17.25 per share. | 11 Aug 2022 | 5,000 | 218,271 (0%) | 0% | 17.3 | 86,250 | Common Stock |
| Allogene Therapeutics Inc | Owen N. Witte | Director | Sale of securities on an exchange or to another person at price $ 11.76 per share. | 22 Jun 2022 | 10,000 | 233,271 (0%) | 0% | 11.8 | 117,600 | Common Stock |
| Allogene Therapeutics Inc | Owen N. Witte | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 35,535 | 35,535 | - | - | Stock Option (Right to Buy) | |
| Allogene Therapeutics Inc | Owen N. Witte | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 22,089 | 243,271 (0%) | 0% | 0 | Common Stock | |
| Allogene Therapeutics Inc | Owen N. Witte | Director | Sale of securities on an exchange or to another person at price $ 25.54 per share. | 09 Sep 2021 | 5,000 | 221,182 (0%) | 0% | 25.5 | 127,700 | Common Stock |
| Allogene Therapeutics Inc | Owen N. Witte | Director | Sale of securities on an exchange or to another person at price $ 23.24 per share. | 20 Aug 2021 | 5,000 | 226,182 (0%) | 0% | 23.2 | 116,200 | Common Stock |
| Allogene Therapeutics Inc | Owen N. Witte | Director | Sale of securities on an exchange or to another person at price $ 23.70 per share. | 20 Aug 2021 | 5,000 | 231,182 (0%) | 0% | 23.7 | 118,500 | Common Stock |
| Allogene Therapeutics Inc | Owen N. Witte | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2021 | 28,015 | 28,015 | - | - | Stock Option (Right to Buy) | |
| Allogene Therapeutics Inc | Owen N. Witte | Director | Sale of securities on an exchange or to another person at price $ 25.05 per share. | 09 Jun 2021 | 9,969 | 236,182 (0%) | 0% | 25.0 | 249,723 | Common Stock |